Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Gen Physiol
2016 Jun 01;1476:497-505. doi: 10.1085/jgp.201611601.
Show Gene links
Show Anatomy links
Polymodal activation of the TREK-2 K2P channel produces structurally distinct open states.
McClenaghan C
,
Schewe M
,
Aryal P
,
Carpenter EP
,
Baukrowitz T
,
Tucker SJ
.
???displayArticle.abstract???
The TREK subfamily of two-pore domain (K2P) K(+) channels exhibit polymodal gating by a wide range of physical and chemical stimuli. Crystal structures now exist for these channels in two main states referred to as the "up" and "down" conformations. However, recent studies have resulted in contradictory and mutually exclusive conclusions about the functional (i.e., conductive) status of these two conformations. To address this problem, we have used the state-dependent TREK-2 inhibitor norfluoxetine that can only bind to the down state, thereby allowing us to distinguish between these two conformations when activated by different stimuli. Our results reconcile these previously contradictory gating models by demonstrating that activation by pressure, temperature, voltage, and pH produce more than one structurally distinct open state and reveal that channel activation does not simply involve switching between the up and down conformations. These results also highlight the diversity of structural mechanisms that K2P channels use to integrate polymodal gating signals.
???displayArticle.pubmedLink???
27241700
???displayArticle.pmcLink???PMC4886281 ???displayArticle.link???J Gen Physiol ???displayArticle.grants???[+]
Figure 1. The down state can be conductive. (A, left) Structure of TREK-2 in the down state showing NFx (as colored spheres) bound within the fenestrations (Dong et al., 2015). K+ ions within the filter are shown in magenta. (right) Cartoon model illustrating how activation by membrane stretch reduces inhibition by NFx (red pentagon). In the unbound down state (middle), the filter gate is closed. The NFx-binding site is only found in the down state; thus, channel activation by membrane stretch (up state, blue) reduces availability of the NFx-binding site. This binary two-state model of gating assumes the down state is always closed and the up state is always open. (B) Relative position of the filter gate mutations (G167I and W306S) that directly activate TREK-2 and the Y315A mutation in TM4, which affects movement between the down and up states. (C) All three mutations produce similar increases in basal whole-cell currents recorded at 100 mV (n ⥠20; left) and similar reductions in fold activation by membrane stretch (right); currents were recorded in inside-out patches at 0 mV before and after application of negative pressure. Error bars shown are mean ± SEM (n = 5). (D) Example traces showing inhibition by 30 µM NFx inhibition for WT and mutant channels. The voltage protocol involves a step to 0 mV from a holding potential of â80 mV, followed by a ramp from â100 to 60 mV. (E) Doseâresponse curves showing NFx inhibition is unaffected by the filter gate mutations (G167I and W306S) but reduced by the Y315A mutation. WT IC50 4.9 ± 0.5 µM, n = 16 compared with G167I (IC50 7.0 ± 0.6 µM, n = 10), W306S (IC50 5.0 ± 0.4 µM, n = 10), and Y315A (IC50 > 30 µM, n = 8). Error bars shown are mean ± SEM (n ⥠6). (F) Revised gating model showing that channels activated by the filter gate mutations are in the down state, whereas activation by the Y315A mutation affects movement between states to reduce NFx inhibition.
Figure 2. Dynamic interconversion between structurally distinct open conformations. (A) Example showing WT TREK-2 currents from an inside-out patch; at pHi 7.4, channels can be inhibited by 10 µM NFx (effect magnified within inset dashed box). Channels were then stretch activated by application of negative pressure (â11 mmHg suction to the pipette), whereupon NFx inhibition is markedly reduced. Currents were recorded from voltage steps to 0 mV from a holding potential of â80 mV. The dashed line indicates the zero current level. (B) Similar dynamic changes in NFx inhibition can also be observed for channels activated by intracellular acidification (pHi 6.0), demonstrating that these two activated states are structurally distinct. (C) Summary of dynamic changes in NFx inhibition seen for stretch activation but not pHi activation. (D) Repeated NFx application produces consistent inhibition of the G167I mutant channel. The red arrows indicate distinct structural states of the channel. (E) Example experiment (similar to that shown in A and B) showing a dynamic change in NFx inhibition for the G167I mutant as the channel is converted from the down state to the up by membrane stretch. (C and E) Error bars shown are mean ± SEM (n ⥠6). (F) Cartoon illustrating conversion between different structural states of the channel. The numbers refer to states shown by the red arrows in D. (left) The G167I mutation directly activates the filter gate in the down state, and the NFx-binding site remains available, but when the same channel is subjected to membrane stretch (right), it is converted into the up state, which exhibits reduced NFx sensitivity as the result of closure of the fenestration binding site.
Figure 3. Direct activation of the filter gate without major conformational changes. (A) Example traces from inside-out patches showing activation of TREK-2 currents upon exchange of intracellular K+ for Rb+. (B) Summary doseâresponse curves showing NFx inhibition of TREK-2 does not change when Rb+ is used as the permeant ion to directly activate the filter gate. (C) Example showing activation of whole-cell currents upon extracellular acidification. Bar chart shows the effect of the H156A and E103Q mutations that abolish pHext activation by interfering with the filter gating mechanism (Dong et al., 2015). (D) Doseâresponse curves from two-electrode voltage clamp recordings of whole-cell currents showing that neither mutation reduces NFx inhibition (WT IC50 = 23.4 ± 3.9 µM, n = 10; E103Q IC50 = 18.3 ± 2.3 µM, n = 7; H156A IC50 19.1 ± 2.1 µM, n = 11). Note that when applied extracellularly, higher concentrations of NFx are required to inhibit channel activity. (BâD) Error bars shown are mean ± SEM (n ⥠6).
Figure 4. Temperature activation involves conformational changes in the TM helices. (A) Example traces showing that temperature-dependent activation of whole-cell TREK-2 currents from 22°C (left) to 37°C (right) markedly decreases inhibition by 100 µM NFx. For comparison, the currents at 22°C are also shown in gray in the right panel. Currents were recorded by voltage protocols similar to those used in Fig. 1 D. (B) Summary doseâresponse curves showing reduced NFx sensitivity of whole-cell TREK-2 currents at 22°C, 37°C, and 42°C (data shown are percent inhibition of basal currents recorded at 0 mV; mean ± SEM, n ⥠6). IC50 at 22°C, 23.4 ± 3.1 µM; but at 37°C and 42°C, >100 µM. (C) A truncated version of TREK-2 (TREK2 ÎN/ÎC) that no longer responds to temperature. Fold activation represents change in current between 22°C and 37°C. (D) The NFx sensitivity of this temperature-insensitive mutant is unaffected by temperature, indicating a specific effect on WT TREK-2. (C and D) Error bars shown are mean ± SEM (n ⥠6).
Figure 5. Expanded gating model for TREK-2 activation. This cartoon illustrates how structurally distinct open states (e.g., O1 and O2) can be produced by different activatory stimuli. The model allows for the filter to gate independently in both the up and down conformations. The dotted line illustrates how the major conformational changes in the TM helices caused by, e.g., membrane stretch and temperature can also influence the filter gating mechanism. The model also shows how the channel can interconvert between different open states in response to membrane stretch.
Acosta,
TREK2 expressed selectively in IB4-binding C-fiber nociceptors hyperpolarizes their membrane potentials and limits spontaneous pain.
2014, Pubmed
Acosta,
TREK2 expressed selectively in IB4-binding C-fiber nociceptors hyperpolarizes their membrane potentials and limits spontaneous pain.
2014,
Pubmed
Baez-Nieto,
Thermo-TRP channels: biophysics of polymodal receptors.
2011,
Pubmed
Bagriantsev,
Multiple modalities converge on a common gate to control K2P channel function.
2011,
Pubmed
Bagriantsev,
Metabolic and thermal stimuli control K(2P)2.1 (TREK-1) through modular sensory and gating domains.
2012,
Pubmed
,
Xenbase
Bockenhauer,
KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel.
2001,
Pubmed
,
Xenbase
Brohawn,
Crystal structure of the human K2P TRAAK, a lipid- and mechano-sensitive K+ ion channel.
2012,
Pubmed
Brohawn,
Physical mechanism for gating and mechanosensitivity of the human TRAAK K+ channel.
2014,
Pubmed
Brohawn,
Domain-swapped chain connectivity and gated membrane access in a Fab-mediated crystal of the human TRAAK K+ channel.
2013,
Pubmed
Cao,
TRPV1 structures in distinct conformations reveal activation mechanisms.
2013,
Pubmed
Clapham,
A thermodynamic framework for understanding temperature sensing by transient receptor potential (TRP) channels.
2011,
Pubmed
Dong,
K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac.
2015,
Pubmed
Enyedi,
Molecular background of leak K+ currents: two-pore domain potassium channels.
2010,
Pubmed
Hille,
The pH-dependent rate of action of local anesthetics on the node of Ranvier.
1977,
Pubmed
Honoré,
An intracellular proton sensor commands lipid- and mechano-gating of the K(+) channel TREK-1.
2002,
Pubmed
Kang,
Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK.
2005,
Pubmed
Kang,
TREK-2 (K2P10.1) and TRESK (K2P18.1) are major background K+ channels in dorsal root ganglion neurons.
2006,
Pubmed
Kennard,
Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine.
2005,
Pubmed
Kim,
Synergistic interaction and the role of C-terminus in the activation of TRAAK K+ channels by pressure, free fatty acids and alkali.
2001,
Pubmed
Kim,
Localization of TREK-2 K+ channel domains that regulate channel kinetics and sensitivity to pressure, fatty acids and pHi.
2001,
Pubmed
Liu,
Ion-binding properties of a K+ channel selectivity filter in different conformations.
2015,
Pubmed
Lolicato,
Transmembrane helix straightening and buckling underlies activation of mechanosensitive and thermosensitive K(2P) channels.
2014,
Pubmed
,
Xenbase
Maingret,
TREK-1 is a heat-activated background K(+) channel.
2000,
Pubmed
,
Xenbase
Maingret,
Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel.
1999,
Pubmed
Pereira,
Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception.
2014,
Pubmed
Piechotta,
The pore structure and gating mechanism of K2P channels.
2011,
Pubmed
Rapedius,
State-independent intracellular access of quaternary ammonium blockers to the pore of TREK-1.
2012,
Pubmed
,
Xenbase
Renigunta,
Much more than a leak: structure and function of K₂p-channels.
2015,
Pubmed
Sandoz,
Extracellular acidification exerts opposite actions on TREK1 and TREK2 potassium channels via a single conserved histidine residue.
2009,
Pubmed
,
Xenbase
Schewe,
A Non-canonical Voltage-Sensing Mechanism Controls Gating in K2P K(+) Channels.
2016,
Pubmed
Schneider,
Temperature sensitivity of two-pore (K2P) potassium channels.
2014,
Pubmed
Sepúlveda,
Molecular aspects of structure, gating, and physiology of pH-sensitive background K2P and Kir K+-transport channels.
2015,
Pubmed
Zilberberg,
KCNKØ: opening and closing the 2-P-domain potassium leak channel entails "C-type" gating of the outer pore.
2001,
Pubmed
,
Xenbase